TRAX

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued

NASDAQ: TRAXV · HEALTHCARE · BIOTECHNOLOGY

$22.51

+0.00% today

Updated 2026-04-30

Market cap

$782.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$—

Dividend yield

—

52W range

$15 – $27

Volume

0.0M

Market cap

$782.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$—

Dividend yield

—

52W range

$15 – $27

Volume

0.0M

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price

$22.51

12-Month target

—

2030 Target

—

Intrinsic (DCF)

—

Financial forecast

Metric	2023	2024
Revenue	$0.0B	$0.0B
EPS	—	—

CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.